SXC Health Solutions announces appointment to board of directors

- Company also completes official name change to SXC Health Solutions Corp. -  

Lisle, Illinois, July 27, 2007, SXC Health Solutions, Corp. (formerly Systems Xcellence, Inc.) (“SXC” or the “Company”) (NASDAQ: SXCI, TSX: SXC), a leading provider of pharmacy benefits management services, is pleased to announce that Mr. Steven D. Cosler, 52, Operating Partner at Water Street Healthcare Partners (“Water Street”), a Chicago-based private-equity firm focused exclusively on the healthcare industry, has joined its Board of Directors.   

“Steve brings senior management and director-level experience to our board along with a proven track record for operating and creating shareholder value with a rapidly growing Fortune 1000 healthcare company,” said Gordon S. Glenn, Chairman and CEO of SXC.  “We look to draw on his experience in both the specialty pharmacy and distribution markets as well as his experience in the healthcare services industry.” 

In 2006, Mr. Cosler became an Operating Partner at Water Street.  Prior to joining Water Street, Mr. Cosler was President and CEO of Priority Healthcare Corporation {“Priority”), a publicly held specialty pharmacy and distributor generating $2.2 billion in annual revenue that was acquired by Express Scripts in October 2005.  Mr. Cosler was employed by Priority from 1996-2005, where he held a number of increasingly senior roles, culminating in his appointment as President and COO in 2001, and President and CEO in 2002, a position he retained until the acquisition.   

Before joining Priority, Mr. Cosler held leadership positions at Coresource, Inc., a Third Party Administrator managing healthcare services, and at IBM.  Mr. Cosler sits on the board of several privately-held healthcare companies including CCS Medical, Inc. and Access Mediquip, Inc.  He is a graduate of Purdue University with a Bachelor of Science degree in Industrial Management. 

Other Corporate Developments

The Corporation is also pleased to announce that it has changed its name to "SXC Health Solutions Corp." and that effective June 27, 2007 it completed its continuance from the jurisdiction of the Canada Business Corporations Act to the jurisdiction of the Business Corporations Act (Yukon).  Shareholders approved the name change and the continuance at the annual and special meeting of shareholders held on May 16, 2007.  Further information regarding these developments can be found in the Company’s Management Information Circular filed at www.sedar.com    

About SXC Health Solutions

SXC Health Solutions, Inc. (SXC) is a leading provider of pharmacy benefits management (PBM) services and healthcare IT solutions to the healthcare benefits management industry. The Company's product offerings and solutions combine a wide range of software applications, application service provider (ASP) processing services and professional services, designed for many of the largest organizations in the pharmaceutical supply chain, such as Federal, provincial, and, state and local governments, pharmacy benefit managers, managed care organizations, retail pharmacy chains and other healthcare intermediaries. SXC is based in Lisle, Illinois with locations in; Scottsdale, Arizona; Warminster, Pennsylvania; Alpharetta, Georgia; Milton, Ontario and Victoria, British Columbia. For more information please visit www.sxc.com.

Forward-Looking Statements

Certain statements included herein, including those that express management's expectations or estimates of our future performance, constitute "forward-looking statements" within the meaning of applicable securities laws.   Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies.   We caution that such forward-looking statements involve known and unknown risks, uncertainties and other risks that may cause our actual financial results, performance, or achievements to be materially different from our estimated future results, performance or achievements expressed or implied by those forward-looking statements.   Numerous factors could cause actual results to differ materially from those in the forward-looking statements, including without limitation, our ability to achieve increased market acceptance for our product offerings and penetrate new markets; consolidation in the healthcare industry; the existence of undetected errors or similar problems in our software products; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; our ability to compete successfully; potential liability for the use of incorrect or incomplete data; the length of the sales cycle for our healthcare software solutions; interruption of our operations due to outside sources; our dependence on key customers; maintaining our intellectual property rights and litigation involving intellectual property rights; our ability to obtain, use or successfully integrate third-party licensed technology; compliance with existing laws, regulations and industry initiatives and future change in laws or regulations in the healthcare industry; breach of our security by third parties; our dependence on the expertise of our key personnel; our access to sufficient capital to fund our future requirements; and potential write-offs of goodwill or other intangible assets.  This list is not exhaustive of the factors that may affect any of our forward-looking statements.  Investors are cautioned not to put undue reliance on forward-looking statements.  All subsequent written and oral forward-looking statements attributable to SXC or persons acting on our behalf are expressly qualified in their entirety by this notice.  We disclaim any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.   Risks and uncertainties about our business are more fully discussed in our Annual Information Form. 

Certain of the assumptions made in preparing forward-looking information and management’s expectations include: maintenance of our existing customers and contracts, our ability to market our products successfully to anticipated customers, the impact of increasing competition, the growth of prescription drug utilization rates at predicted levels, the retention of our key personnel, our customers continuing to process transactions at historical levels, that our systems will not be interrupted for any significant period of time, that our products will perform free of major errors, our ability to obtain financing on acceptable terms and that there will be no significant changes in the regulation of our business.

  Click here for PDF 

Back to Press Releases 2007

For more information, please contact: 
 

Jeff Park	Dave Mason	Susan Noonan	Judith Sylk-Siegel
Chief Financial Officer	Investor Relations - Canada	Investor Relations – U.S.	Media Contact
Systems Xcellence Inc.	The Equicom Group Inc.	The SAN Group, LLC	Rx Communications Group
Tel: (630) 559-3693	416-815-0700 ext. 237	(212) 966-3650	(917) 322-2164
investors@sxc.com	dmason@equicomgroup.com	susan@sanoonan.com	jsylksiegel@rxir.com